Haemostatic patch and method of preparation

Abstract
The present invention relates to a haemostatic patch comprising a porous layer based on oxidized cellulose and a neutralized film based on chitosan, said film comprising a free face and a face fixed on one of the faces of the porous layer, and to the method of preparing said patch comprising the following steps: —a°) preparing a porous layer based on oxidized cellulose, —b°) preparing a film based on chitosan starting from an acidic aqueous solution of chitosan, —c°) fixing the film obtained in b°) on one face of the porous layer, —d°) neutralizing the film obtained in b°), —where step c°) can be carried out before or after step d°), characterized in that: the neutralizing step d°) comprises treatment of said film with a neutralizing composition comprising at least ethanol and ammonium hydroxide (NH4OH).
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a National Stage Application of PCT/EP13/069957 under 35USC §371 (a), which claims priority of French Patent Application Serial No. 12/58965 filed Sep. 25, 2012, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.


BACKGROUND

1. Technical Field


The present invention relates to a method of preparing a haemostatic patch comprising a porous layer, for example a textile, based on oxidized cellulose and a film based on neutralized chitosan fixed on one of the faces of the porous layer.


2. Description of Related Art


Haemostatic patches are implantable medical devices for stopping the flow of biological fluids such as blood during surgery. For this purpose, they are generally composed of an absorbent porous layer, which is intended to trap the biological fluids, and a barrier known as a haemostatic barrier, which is intended to block the passage of the biological fluids.


Some haemostatic patches can be completely bioabsorbable, i.e. they are made to disappear in vivo after implantation, after a few weeks for example, when their function of stopping the effusion of biological fluids is no longer necessary.


Oxidized cellulose is of interest as a bioabsorbable material that can constitute the absorbent porous layer of a haemostatic patch: in fact, oxidized cellulose possesses intrinsic haemostatic properties.


Chitosan is a polysaccharide obtained by deacetylation of chitin. Chitin is one of the most widespread naturally occurring polysaccharides and is extracted from the exoskeletons of arthropods, from the endoskeletons of cephalopods as well as from fungi.


Chitosan has properties, such as biodegradability, bioabsorbability, biocompatibility, non-toxicity, and mechanical properties, that make it particularly interesting for medical applications. Thus, it would be interesting to combine a porous layer of oxidized cellulose with a film based on chitosan with a view to preparing a haemostatic patch. Chitosan in fact offers a good compromise, taking into account the properties that are required, for a haemostatic barrier, namely good biocompatibility and good mechanical properties.


However, chitosan is generally soluble in an acid environment. Thus, the films obtained from acid solutions based on chitosan are still highly laden with salts and still have their acid character. A chitosan film obtained from an acidic solution of chitosan can thus degrade and disintegrate when it is brought in contact with water or biological fluids. Therefore it can no longer perform its function of haemostatic barrier.


Accordingly, in order to be used in medical devices, especially in haemostatic patches, chitosan films must be neutralized. Generally this neutralization is obtained by treating these films with a strong base such as sodium hydroxide.


However, this treatment with sodium hydroxide can affect the integrity of the part of the patch supporting the chitosan film: thus, in the case of a haemostatic patch with an absorbent porous layer based on oxidized cellulose, treatment of the chitosan barrier film with sodium hydroxide would destroy the porous layer of oxidized cellulose.


Thus, it would be desirable to employ a method of preparing a haemostatic patch comprising a porous layer based on oxidized cellulose and a barrier film based on chitosan, which would avoid the phenomenon of degradation of the porous layer during the necessary neutralization of the chitosan film.


SUMMARY

The present invention relates to a method of preparing a haemostatic patch comprising a porous layer based on oxidized cellulose and a neutralized film based on chitosan, said film comprising a free face and a face fixed on one of the faces of the porous layer, comprising the following steps:

    • a°) preparing a porous layer based on oxidized cellulose,
    • b°) preparing a film based on chitosan starting from an acidic aqueous solution of chitosan,
    • c°) fixing the film obtained in b°) on one face of the porous layer,
    • d°) neutralizing the film obtained in b°),
    • where step c°) can be carried out before or after step d°), characterized in that:


the neutralizing step d°) comprises treatment of said film with a neutralizing composition comprising at least ethanol and ammonium hydroxide (NH4OH).


With the method according to the invention it is possible to obtain haemostatic patches based on a porous layer of oxidized cellulose and a chitosan barrier film without the risk of the chitosan film dissolving in contact with biological fluids, in particular in contact with blood. According to the method of the invention, firstly a film based on chitosan is manufactured starting from an acidic solution, then this film, alone or already fixed on the porous layer based on oxidized cellulose, is treated in order to neutralize it and obtain a final product usable in contact with biological fluids, without destroying the porous layer to which this film is attached. Regardless of the order of steps) c°) and d°) of the method according to the invention, the neutralizing composition of the method of the invention, comprising at least ethanol and ammonium hydroxide (NH4OH), makes it possible to neutralize the chitosan-based film without damaging the porous layer based on oxidized cellulose. In particular, neutralization by means of a neutralizing composition comprising at least ethanol and ammonium hydroxide (NH4OH) makes it possible to neutralize the chitosan-based film both at the surface and throughout its thickness, whether or not it is already fixed to the porous layer based on oxidized cellulose, without damaging said porous layer. With the method of the invention, it is possible to obtain a haemostatic patch having a film of neutralized chitosan as barrier, with a porous layer fixed to this film, said porous layer being based on oxidized cellulose, or said porous layer consisting of oxidized cellulose.


The present invention further relates to a haemostatic patch comprising a porous layer based on oxidized cellulose and a film based on chitosan fixed to one face of said porous layer, characterized in that said film is in neutralized form.


The present invention further relates to a haemostatic patch obtained by the method herein described, comprising a porous layer based on oxidized cellulose and a film based on chitosan fixed to one face of said porous layer, characterized in that said film is in neutralized form.


In one embodiment of the invention, the treatment in step d°) comprises a succession of operations of contacting at least the face that is free, or is intended to be free, of the film with said neutralizing composition. For example, if the film is fixed to the porous layer before it is neutralized, the treatment in step d°) will essentially consist of contacting only the free face of the film with the neutralizing composition, preferably without contacting the porous layer, on which the film will already be fixed: in fact, contact of the porous layer with the neutralizing composition could affect the integrity of the latter. Alternatively, if the film is neutralized before being fixed to the porous layer, the treatment in step d°) can comprise immersing the whole film, i.e. both of its faces, in a bath of the neutralizing composition. In both cases, the chitosan-based film is neutralized effectively at the surface and through its thickness, and the integrity of the porous layer is unaffected by the neutralizing composition comprising ethanol and ammonium hydroxide (NH4OH).


In one embodiment of the invention, step d°) further comprises a step of washing of said face of said film that is free, or intended to be free, after said treatment with the neutralizing composition. For example, the washing step comprises one or more operations of rinsing of at least said face of said film that is free, or intended to be free, with an ethanol/water composition followed by washing with water. Thus, if the film is fixed to the porous layer before it is neutralized, only its free face will be washed after application of the neutralizing composition. Alternatively, if the film is neutralized before being fixed on the porous layer, the whole film can be immersed in an ethanol/water composition and/or in water.


In one embodiment of the invention, the fixing step c°) is carried out before the neutralizing step d°). In such a case, for example, according to step b°), the acidic aqueous solution of chitosan is poured into a mould in the form of one or more layers, which are left to dry by evaporation of the water from said solution in order to obtain a film, then, according to step c°), before the end of the drying step of step b°), one face of the porous layer of oxidized cellulose is deposited on said film, complete drying of the film thus resulting in fixation of the porous layer on the film. In fact, when the porous layer is deposited on the film that is still in the course of drying, it penetrates superficially into the film under the action of the force of gravity. Thus, as drying is completed, the film traps the portion of the porous layer that has thus sunk slightly, thus providing fixation of the porous layer on the film. According to this embodiment of the invention, the treatment in step d°) comprises application of said neutralizing composition on the free face of the film, said neutralizing composition further comprising water. In such an embodiment of the invention, said neutralizing composition can for example consist of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight. This formulation for the neutralizing composition of the method of the invention makes it possible to achieve effective neutralization of the film on its surface and through its thickness while avoiding causing shrinkage of the film, without damaging the integrity of the porous layer on which the film is already fixed.


In such an embodiment of the invention, for example, the neutralizing composition is applied on the free face of the film one or more times using a brush. For example, the bristles of a brush are soaked in neutralizing composition consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight and the free face of the film is brushed: several passes of the brush can be carried out, for example 3 passes. The film is thus neutralized. The film is then washed, as described above: for example, another brush is used, which is soaked with an ethanol/water composition, for example in the proportions 50/50 by weight. Several passes of the brush can be carried out, for example three. A last pass with a brush soaked in just water can be carried out to finalize the washing.


In another embodiment of the invention, the neutralizing step d°) is carried out before the fixing step c°). In such a case, for example, according to step b°), the acidic aqueous solution of chitosan is poured into a mould in the form of one or more layers, which are left to dry by evaporation of the water until a film is obtained, which is removed from the mould, then, according to step d°), the treatment of the film obtained in b°) comprises immersing said film in said neutralizing composition, preferably for 30 minutes. In such an embodiment, for example, once the film is completely dry and can be handled, it is immersed completely in a bath of neutralizing composition. Thus, in such a case, both faces of the film are treated with the neutralizing composition. In such an embodiment of the invention, the neutralizing composition can consist of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight. This formulation for the neutralizing composition of the method of the invention makes it possible to carry out effective neutralization of the film without damaging the integrity of the porous layer when the film is to be fixed on the porous layer in the next step.


After immersion in a bath of the neutralizing composition as described above, the chitosan-based film is thus neutralized. The film can then be washed, as described above: for example, the film is immersed one or more times in baths of an ethanol/water composition, for example in the proportions 50/50 by weight, until a pH close to 7 is obtained for the washing baths. The film can then be submitted to a last bath of water only, to finalize the washing.


In such an embodiment, according to step c°), the neutralized film obtained at the end of step d°) can be fixed on one face of the porous layer of oxidized cellulose by means of a glue obtained starting from an acidic solution of chitosan. For example, said glue is spread on one face of the porous layer and/or on the face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on said face of the porous layer with pressure. The integrity of the porous layer based on oxidized cellulose is not affected during this fixing step.


Regardless of the order of steps c°) and d°) described above, a plasticizer, for example glycerol, can be added to the acidic aqueous solution of chitosan intended to form said chitosan-based film. With such an embodiment, a chitosan film can finally be obtained that has excellent mechanical properties.


In one embodiment of the invention, the porous layer is a textile, preferably a three-dimensional knitted fabric. Said porous layer, in the form of three-dimensional knitted fabric, gives excellent absorption of biological fluids, especially of blood.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention and its advantages will become clearer from the following detailed description and the drawings in which:



FIGS. 1A-1C are sectional views showing the various steps of a first implementation of the method according to the invention,



FIGS. 2A-2E are sectional views showing the various steps of a second implementation of the method according to the invention.





DETAILED DESCRIPTION

According to a first step of the method according to the invention, step a°), a porous layer based on oxidized cellulose is provided. “Based on oxidized cellulose” means, according to the present application, that the main component of the porous layer is oxidized cellulose. The porous layer can further comprise other biocompatible, preferably bioabsorbable, materials. For example, the porous layer can comprise, as other bioabsorbable materials, synthetic polymers such as polylactic acid and/or polymers of natural origin such as chitosan.


Oxidized cellulose is a known bioabsorbable material. It can for example be selected from oxidized cellulose, where the C6 primary alcohol is partially or fully oxidized to carboxylic acid, for example to give polyglucuronic acid, oxidized cellulose in the form of polyaldehydes by periodic acid, and mixtures thereof. The cellulose used for oxidation can be obtained from type I cellulose or can be regenerated.


Several types of regenerated cellulose have been developed industrially. We may mention for example the “viscose” process, which is based on the solubility of cellulose xanthate in a dilute solution of sodium hydroxide. We may also mention the so-called “cupro-ammonium process” employed for example by the company Bemberg in Italy or the company Asahi Chemical Industries in Japan, which consists of dissolving cellulose in an ammoniacal solution of copper. Another method of preparing regenerated cellulose suitable for the present invention is the method of organic-phase dissolution of cellulose by N-methylmorpholine oxide (N.M.M.O.), called the “Lyocell® process”, employed for example by the company Lenzing in Austria.


In the present application, “porous layer” means a layer having pores, or voids, cells, holes, orifices, distributed regularly or irregularly, not only on the surface but also within the thickness of said layer, and more or less interconnected. Said porous layer is particularly effective for absorbing biological fluids such as blood.


In one embodiment, the porous layer based on oxidized cellulose is in the form of a textile openwork based on oxidized cellulose.


According to the present application, “textile” means any arrangement or assemblage of biocompatible threads, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or alternatively non-woven. The arrangement of threads of the textile according to the invention defines at least two opposite faces, a first face and a second face.


In the present application, “textile openwork” means any textile whose arrangement of threads of which it is constituted determines openings, cells or voids in the thickness of the textile and on the faces of the textile, and these openings, cells or voids can constitute channels with openings on either side of the textile. This textile openwork gives good absorption of biological fluids.


The textile can be in the form of a two-dimensional or three-dimensional knitted fabric.


“Two-dimensional knitted fabric” means, in the sense of the present application, a knitted fabric having two opposite faces joined together by stitches but lacking cross-members giving it a certain thickness: a knitted fabric of this kind can be obtained for example by knitting threads on a warp knitting machine or Raschel machine using two guide bars. Examples of knitting of two-dimensional knitted fabrics suitable for the present invention are given in document WO2009/071998.


“Three-dimensional knitted fabric” means, according to the present application, a knitted fabric having two opposite faces joined together by a cross-member giving the knitted fabric a significant thickness, said cross-member itself being formed of additional connecting threads supplementary to the threads forming the two faces of the knitted fabric. This knitted fabric can be obtained for example on a warp knitting machine or double-bed Raschel machine using several guide bars. Examples of knitting of three-dimensional knitted fabrics suitable for the present invention are given in documents WO99/05990, WO2009/031035, WO2009/071998.


This kind of three-dimensional knitted fabric, with the presence of a cross-member giving it a significant thickness, provides excellent absorption of biological fluids such as blood and is particularly suitable for manufacture of the haemostatic patch of the invention.


A knitted fabric, in particular three-dimensional, based on oxidized cellulose, can be obtained by knitting firstly threads of unoxidized regenerated cellulose, then submitting the knitted fabric thus obtained to oxidation.


In fact, when spun through a perforated plate, viscose sets in an acid medium and forms long continuous filaments of regenerated cellulose, which are dried and combined in multifilament threads. A regenerated cellulose thread is obtained that has good mechanical strength.


Generally this regenerated cellulose thread is not absorbable. However, it has good mechanical strength allowing it to be used for manufacturing a knitted fabric. As an example, we may mention, as regenerated cellulose thread suitable for manufacturing a knitted fabric suitable for the porous layer of the patch of the invention, the 90 decitex multifilament thread marketed under the name “CUPRO® Cusio” by the Italian company Bemberg.


The knitted fabric obtained is then oxidized in order to form a porous layer based on oxidized cellulose suitable for the haemostatic patch and for the method of preparing said patch according to the present invention.


In a preferred embodiment of the method of the invention, the porous layer based on oxidized cellulose is a three-dimensional knitted fabric made from oxidized cellulose.


According to a second step of the method according to the invention, step b), a film based on chitosan is prepared starting from an acidic aqueous solution of chitosan.


“Based on chitosan” means, according to the present application, that the main component of the film is chitosan. The chitosan-based film can further comprise other compounds. For example, the chitosan-based film can comprise a plasticizer, for example glycerol, to improve the mechanical properties of the film.


Chitosan is a biocompatible biopolymer obtained by deacetylation of chitin. Chitin is extracted from exoskeletons of arthropods such as the lobster, crab, prawn, the endoskeleton of cephalopods such as the squid, or from fungi. Extraction of chitin involves steps of hydrolysis of the proteins and lipids, depigmentation and demineralization. Hydrolysis of the proteins and lipids is usually carried out in the presence of sodium hydroxide, and demineralization requires the use of hydrochloric acid.


Once the chitin has been extracted, chitosan is obtained by a deacetylation step, which consists of hydrolysis of the acetamide groups. This reaction is generally carried out at high temperature in an alkaline solution, for example a 48% solution of sodium hydroxide (NaOH) in water, at 90° C. Chitosan is a compound that is soluble in aqueous solution and can have a degree of acetylation (DA) of up to 70%.


The following publications describe processes for deacetylation of chitin to obtain chitosan: “Lamarque, G., C. Viton, and A. Domard, New Route of Deacetylation of α- and β-Chitins by means of Freeze-Pump Out-Thaw Cycles. Biomacromolecules, 2005. 6 (3): p. 1380-1388.”, “Lamarque, G., C. Viton, and A. Domard, Comparative Study of the First Heterogeneous Deacetylation of α- and β-Chitins in a Multistep Process. Biomacromolecules, 2004. 5 (3): p. 992-1001.”, “Lamarque, G., C. Viton, and A. Domard, Comparative Study of the Second and Third Heterogeneous Deacetylations of α- and β-Chitins in a Multistep Process. Biomacromolecules, 2004. 5 (5): p. 1899-1907.”, “Tolaimate, A., et al., Contribution to the preparation of chitins and chitosans with controlled physicochemical properties. Polymer, 2003. 44 (26): p. 7939-7952.”


Chitosan is a bioabsorbable compound. The degree of acetylation of chitosan can have an influence on the kinetics of degradation of chitosan. Thus, depending on the kinetics of biodegradation desired for the film of the haemostatic patch prepared according to the method of the invention, the chitosan will have to have a degree of acetylation of 2, 10, 20, 30, 40, 50, 60 or 70%.


In one embodiment of the method according to the invention, the degree of acetylation of the chitosan ranges from 2 to 70%. With this chitosan it is possible to obtain a film having optimum degradation kinetics for the manufacture of haemostatic patches.


The chitosan solution in step b) of the method according to the invention is generally prepared starting from a solution of chitosan in water, with the concentration of chitosan in said solution ranging for example from 0.25% to 10%, by weight, relative to the total weight of the solution, to which an acid is added in stoichiometric proportion, said acid being selected for example from acetic acid, hydrochloric acid and mixtures thereof. For a chitosan of molecular weight 500 000 Da (500 000 g/mol), for example, the concentration of chitosan in the starting aqueous solution can range from 0.25% to 5%, by weight, relative to the total weight of the solution.


With these chitosan concentrations it is possible to obtain, finally, a film that has good mechanical properties.


In one embodiment of the method according to the invention, the pH of the acidic aqueous solution of chitosan is from 2.5 to 5.5.


In order to form the chitosan-based film of the method of the invention, the acidic aqueous solution of chitosan is poured into a mould in order to form a layer. The acidic aqueous solution can be cast in the mould in the form of one or more layers, depending on the final thickness that is desired for the barrier film of the haemostatic patch. Generally, the mould is of rectangular shape having dimensions compatible with the use of the film obtained as part of a haemostatic patch.


The layer or layers of acidic aqueous solution are left to dry for evaporation of the water present in the acidic aqueous starting solution. Generally this drying step is carried out under a laminar-flow hood.


Drying of the layer or layers of acidic aqueous solution by evaporation of the water as stated above will make it possible to obtain the chitosan-based film used in the method according to the invention.


During step b°) of formation of the chitosan-based film, the water of the acidic aqueous starting solution is evaporated but the acid remains in the film. The film obtained is therefore of an acidic character. This film cannot be used as it is for forming the barrier of the haemostatic patch of the invention, as it would disintegrate very rapidly merely in contact with biological fluids.


Thus, besides a step of fixing the film to the porous layer based on oxidized cellulose, the method according to the invention comprises a step of neutralizing the film obtained in b°), and this neutralizing step can be carried out before or after the fixing step.


In the rest of the description, a first embodiment of the method according to the invention will be described first, according to which, firstly, the film is fixed to the porous layer based on oxidized cellulose, then it is neutralized, while it is already fixed on the porous layer based on oxidized cellulose. A second embodiment of the method according to the invention will then be described, according to which the film is neutralized first, then it is fixed to the porous layer based on oxidized cellulose.


According to the first embodiment of the method according to the invention, before the end of the drying step in step b°) of formation of the film, the porous layer of oxidized cellulose, in particular the three-dimensional knitted fabric, is deposited on the last layer of acidic aqueous solution based on chitosan that is cast. Under the action of gravity, the porous layer, for example the three-dimensional knitted fabric, penetrates superficially within the last layer cast that is drying. In final drying by evaporation of the water that remains in the last layer cast, the film traps the portion of the porous layer, for example of the three-dimensional knitted fabric, that had slightly penetrated into said last layer cast, and the porous layer is thus fixed to the film.


In the case when the film is fixed to the porous layer before it is neutralized, the neutralizing treatment is carried out on the face of the film that has been left free, i.e. on the face of the film that is not attached to the porous layer, in particular to the textile or knitted fabric based on oxidized cellulose.


In this first embodiment of the invention, for example, the neutralizing composition is applied on the free face of the film one or more times with a brush, taking care that the neutralizing composition does not come in contact with the porous layer based on oxidized cellulose. For example, the bristles of a brush are soaked with neutralizing composition consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight and the free face of the film is brushed or painted: several passes of the brush can be carried out, for example 3 passes. This formulation for the neutralizing composition makes it possible to avoid shrinkage of the film during this neutralizing step. Moreover, said formulation for the neutralizing composition and said number of passes make it possible to carry out effective neutralization of the chitosan-based film, both at the surface and throughout its thickness, without damaging the integrity of the porous layer on which the film is already fixed. The film thus loses its acid character and is neutralized.


The film can then be washed: for example, another brush is used, which is soaked with an ethanol/water composition, for example in the proportions 50/50 by weight, and which is brushed over the free face of the film, still without contacting the porous layer, for example the three-dimensional knitted fabric, based on oxidized cellulose. Several passes of the brush can be carried out, for example three, or up to five. A last pass with a brush soaked in water only can be carried out to finalize the washing.


According to the second embodiment of the method according to the invention, the cast layers of acidic aqueous solution from step b°) of formation of the thread are left to dry by complete evaporation of the water and until a film is obtained that can easily be removed from the mould and handled.


The chitosan-based film thus obtained, which has not been neutralized, can be submitted to one or more operations of immersion in baths of said neutralizing composition. For example, the film can be immersed in a bath of neutralizing composition preferably for 30 minutes. Thus, in this second embodiment of the method according to the invention, both faces of the chitosan-based film are treated with the neutralizing composition. In such an embodiment of the invention, the neutralizing composition can consist of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight. This formulation for the neutralizing composition of the method of the invention makes it possible to carry out effective neutralization of the film, both on the surface of the film and in its thickness, without damaging the integrity of the porous layer during the next step of fixation of the film on the porous layer based on oxidized cellulose.


After immersion in a bath of the neutralizing composition as described above, the chitosan-based film has lost its acid character and it is neutralized. The film can then be washed: for example, the film is immersed one or more times in baths of an ethanol/water composition, for example in the proportions 50/50 by weight, until a pH close to 7 is obtained for the washing baths. The film can then be submitted to a last bath of water only to finalize the washing.


In this second embodiment, according to step c°), the neutralized film obtained at the end of step d°) can be fixed on one face of the porous layer of oxidized cellulose, for example on the three-dimensional knitted fabric, by means of a glue obtained starting from an acidic solution of chitosan. For example, said glue is spread on one face of the porous layer and/or on the face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on said face of the porous layer with pressure. The integrity of the porous layer based on oxidized cellulose is not affected during this fixing step.


Regardless of which embodiment described above is used, a patch is obtained comprising a porous layer based on oxidized cellulose, for example a three-dimensional knitted fabric, and a film based on chitosan fixed to one face of this porous layer, the film being in neutralized form. This patch can be used effectively as a haemostatic patch for stopping effusion of blood during a surgical operation. Moreover, this patch can be completely bioabsorbable: it can thus disappear in the weeks following its implantation, for example in less than 4 weeks, once its haemostatic function is no longer required. This thus avoids introducing a foreign body into a patient's body permanently.


EXAMPLES
Example 1

The fixation of a film based on neutralized chitosan on a textile of oxidized cellulose is described in the present example, referring to FIGS. 1A-1C.


A textile of oxidized cellulose 1, which is a porous three-dimensional knitted fabric, as shown in FIG. 1A, is provided. This textile is bioabsorbable.


An acidic solution based on chitosan is prepared by adding acetic acid in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and with a molecular weight of 550 000 Da at 10 wt % in water. 25 wt % of glycerol is added. The presence of glycerol in the acidic starting solution of chitosan then makes it possible to obtain a film that has good mechanical properties.


The acidic solution thus obtained 2 is poured into a rectangular mould 3 as shown in FIG. 1A: for example, from 8 to 30 ml of acidic solution is poured into a mould with dimensions of 10×15 cm. After evaporation of the water present in the solution, a film is obtained.


The solution can be cast in the mould in the form of several successive layers so that a thicker film is finally obtained. For example, three successive layers of acidic solution can be cast.


Before drying the last layer cast of the acidic solution 2, one face of the textile of oxidized cellulose 1, cut to the dimensions of the mould, is deposited on this layer as shown in FIG. 1. Thus, during drying of the last layer cast, the textile becomes fixed to the film obtained once the water has evaporated. A textile of oxidized cellulose 1 with a film 4 of chitosan fixed on one of its faces is thus obtained, as shown in FIG. 1B. At this stage, the chitosan film still has an acidic character and has not been neutralized.


A neutralizing composition is prepared, consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight. A brush 5 is soaked with this neutralizing composition and is applied on the free face of the chitosan film 4, i.e. on the face of the chitosan film which is not attached to the textile of oxidized cellulose 1, as shown in FIG. 1C.


During said application, care is taken not to bring the textile of oxidized cellulose 1 into contact with the neutralizing composition.


The neutralizing composition is applied on said face of the film at least three times. This formulation for the neutralizing composition makes it possible to avoid shrinkage of the film during this neutralizing step.


The neutralization is effective: the film can then be washed with aqueous solutions without risk of redissolving.


Thus, the neutralized film is rinsed by application of a brush soaked in an ethanol/water mixture in proportions of 50/50 by weight. This mixture can be applied several times, preferably up to three times. The film is then washed with water (100% water), either by application of a brush soaked with water, or by immersing in a water bath.


We thus obtain a textile of oxidized cellulose with a chitosan film fixed on one of its faces, said film having been neutralized. With the method of the invention, the textile of oxidized cellulose has not been damaged by the step of neutralization of the chitosan film and this textile has preserved its integrity. Moreover, the chitosan-based film has kept its initial dimensions, even after neutralization.


The textile thus obtained, with one of its faces covered with a film of neutralized chitosan, can be used as haemostatic patch 6 and can be implanted in a human body without risk of the chitosan film disintegrating and disappearing in contact with biological fluids.


The textile part, which is a three-dimensional knitted fabric of oxidized cellulose 1, thus forms a porous layer capable of absorbing blood. The film of neutralized chitosan, for its part, does not degrade in contact with biological fluids, and it acts as a haemostatic barrier.


The whole patch 6, namely the textile part and the film, is bioabsorbable and disappears in less than 4 weeks after implantation.


Said patch 6 is particularly useful for stopping effusions of blood during surgery. Said patch is completely bioabsorbable and disappears in less than 4 weeks after implantation, when its haemostatic function is no longer required.


Example 2

The fixation of a film based on neutralized chitosan to a textile of oxidized cellulose is described in the present example, referring to FIGS. 2A-2E.


An acidic solution based on chitosan is prepared by adding acetic acid in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and a molecular weight of 550 000 Da at 10 wt % in water. 25 wt % of glycerol is added. The presence of glycerol in the acidic starting solution of chitosan then makes it possible to obtain a film that has good mechanical properties.


The acidic solution 2 thus obtained is poured into a rectangular mould 3 as shown in FIG. 2A: for example, from 8 to 30 ml of acidic solution is poured into a mould with dimensions of 10×15 cm. After evaporation of the water present in the solution, a film 4 is obtained, as shown in FIG. 2B.


The solution can be cast in the mould in the form of several successive layers so that a thicker film is finally obtained. For example, three successive layers of acidic solution are cast.


The layers are left to dry until the water has evaporated completely and a dry film 4 is obtained (FIG. 2B), which can easily be manipulated by hand. For example, the layers are left to dry for 2 h at room temperature.


The chitosan film 4 obtained is of an acid character and has not been neutralized. In order to neutralize it, it is immersed in a neutralizing composition 5 consisting of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight: for example, film 4 is immersed in said composition for 30 minutes in an orbital stirrer 6, as shown in FIG. 2C.


The neutralization is effective: the film can then be washed in aqueous solutions without risk of redissolving.


Thus, the neutralized film is rinsed by successive operations of immersion, for example three times, in baths of an ethanol/water mixture in proportions of 50/50 by weight until a pH of 7 is obtained for the rinsing mixture. The film is then washed by immersing in a water bath (100% water).


The film is then left to dry in spread-out form to avoid the formation of creases in the film.


The film of neutralized chitosan thus obtained 7 is then fixed on one face of a textile of oxidized cellulose by means of a glue based on chitosan as explained below, referring to FIGS. 2D and 2E.


To prepare the glue, acetic acid is added in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and a molecular weight of 550 000 Da at 10 wt % in water.


The glue obtained 8 is spread on one face of the film of neutralized chitosan 7 as shown in FIG. 2D. Alternatively, the glue could be spread on the face of the textile for fixing to the film, or both on one face of the film and on the face of the textile to be attached to the film.


A textile of oxidized cellulose 9 is provided, which is a porous three-dimensional knitted fabric as shown in FIG. 2E. This textile is bioabsorbable.


The textile of oxidized cellulose 9 is applied with pressure on the glue 8, as shown in FIG. 2E, and the film 7 of neutralized chitosan is thus fixed to the textile 9.


The “textile+film” assembly can then be dried under a laminar-flow hood.


A textile of oxidized cellulose is thus obtained with a chitosan film fixed on one of its faces, said film having been neutralized. With the method of the invention, the textile of oxidized cellulose has not been damaged by the step of neutralization of the chitosan film and this textile has preserved its integrity. Moreover, the chitosan-based film has a good, smooth and crease-free appearance.


The textile thus obtained, with one of its faces covered with a film of neutralized chitosan, can be used as haemostatic patch 10 and can be implanted in a human body without risk of the chitosan film 7 disintegrating and disappearing in contact with biological fluids.


The textile part, which is a three-dimensional knitted fabric of oxidized cellulose, thus forms a porous layer capable of absorbing blood. The film of neutralized chitosan, for its part, does not degrade in contact with biological fluids, and it acts as a haemostatic barrier.


The whole of patch 10, namely the textile part and the film, is bioabsorbable and disappears in less than 4 weeks after implantation.


Said patch 10 is particularly useful for stopping effusions of blood during surgery. This patch is completely bioabsorbable and disappears in less than four weeks after implantation, when its haemostatic function is no longer required.

Claims
  • 1. A method of preparing a haemostatic patch comprising a porous layer including oxidized cellulose and a film including neutralized chitosan, the film comprising a first free face and a second face fixed on a first face of the porous layer, comprising the following steps: a) preparing a porous layer including oxidized cellulose,b) preparing a film including chitosan starting from an acidic aqueous solution of chitosan,c) fixing the film obtained in b) on a face of the porous layer,d) neutralizing the film obtained in b), wherein step c) is carried out before or after step d) and the neutralizing step d) comprises treating the film with a neutralizing composition comprising at least ethanol and ammonium hydroxide.
  • 2. The method according to claim 1, wherein step d) comprises a succession of operations of contacting at least the first free face of the film with the neutralizing composition.
  • 3. The method according to claim 1, wherein step d) further comprises washing the first free face of the film after treating with the neutralizing composition.
  • 4. The method according to claim 3, wherein the washing comprises one or more operations of rinsing at least the first free face of the film with a composition comprising ethanol and water followed by a washing with water.
  • 5. The method according to claim 1, wherein step c) is carried out before step d).
  • 6. The method according to claim 1, wherein step b) comprises pouring the acidic aqueous solution of chitosan into a mold as at least one layer, and drying the at least one layer by evaporation of water from the acidic aqueous solution to obtain the film.
  • 7. The method according to claim 6, wherein step c) comprises depositing the face of the porous layer of oxidized cellulose on the film prior to the drying of step b) being complete, and allowing the film to dry completely to provide fixation of the porous layer on the film.
  • 8. The method according to claim 7, wherein step d) comprises applying the neutralizing composition to the first free face of the film and the neutralizing composition further comprises water.
  • 9. The method according to claim 8, wherein the neutralizing composition consists of an ethanol/water/ammonium hydroxide mixture in a proportion of 80/16/14 by weight.
  • 10. The method according to claim 7, wherein step d) comprises applying the neutralizing composition on the first free face of the film one or more times using a brush.
  • 11. The method according to claim 1, wherein step d) is carried out before step c).
  • 12. The method according to claim 11, wherein step b) comprises pouring the acidic aqueous solution of chitosan into a mold as at least one layer, and drying the at least one layer by evaporation of water from the acidic aqueous solution until the film is obtained and removed from the mold.
  • 13. The method according to claim 12, wherein step d) comprises immersing the film obtained in step b) in the neutralizing composition.
  • 14. The method according to claim 13, wherein the film obtained in step b) is immersed in the neutralizing composition for 30 minutes.
  • 15. The method according to claim 13, wherein the neutralizing composition consists of an ethanol/ammonium hydroxide mixture in a proportion of 80/20 by weight.
  • 16. The method according to claim 13, wherein step c) comprises fixing the film obtained at the end of step d) on the face of the porous layer of oxidized cellulose by using a glue comprising an acidic solution of chitosan.
  • 17. The method according to claim 16, wherein the glue is spread on the face of the porous layer and/or on the second face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on the face of the porous layer with pressure.
  • 18. The method according to claim 1, wherein the acidic aqueous solution of chitosan of step b) further comprises a plasticizer.
  • 19. The method according to claim 18, wherein the plasticizer comprises glycerol.
  • 20. The method according to claim 1, wherein the porous layer is a textile.
  • 21. The method according to claim 1, wherein the porous layer is a three-dimensional knitted fabric.
  • 22. A haemostatic patch obtained by the method according to claim 1, comprising a porous layer including oxidized cellulose and a film including chitosan fixed to one face of the porous layer, wherein the film is in a neutralized form.
Priority Claims (1)
Number Date Country Kind
12 58965 Sep 2012 FR national
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2013/069957 9/25/2013 WO 00
Publishing Document Publishing Date Country Kind
WO2014/048982 4/3/2014 WO A
US Referenced Citations (476)
Number Name Date Kind
1187158 Mcginley Jun 1916 A
3054406 Usher Sep 1962 A
3118294 Van Laethem Jan 1964 A
3124136 Usher Mar 1964 A
3272204 Charles et al. Sep 1966 A
3276448 Usher Oct 1966 A
3320649 Naimer May 1967 A
3364200 Ashton et al. Jan 1968 A
3570482 Emoto et al. Mar 1971 A
3718725 Hamano Feb 1973 A
4006747 Kronenthal et al. Feb 1977 A
4060081 Yannas et al. Nov 1977 A
4173131 Pendergrass et al. Nov 1979 A
4193137 Heck Mar 1980 A
4248064 Odham Feb 1981 A
4294241 Miyata Oct 1981 A
4307717 Hymes et al. Dec 1981 A
4338800 Matsuda Jul 1982 A
4476697 Schafer et al. Oct 1984 A
4487865 Balazs et al. Dec 1984 A
4500676 Balazs et al. Feb 1985 A
4511653 Play et al. Apr 1985 A
4527404 Nakagaki et al. Jul 1985 A
4591501 Cioca May 1986 A
4597762 Walter et al. Jul 1986 A
4603695 Ikada et al. Aug 1986 A
4631932 Sommers Dec 1986 A
4670014 Huc et al. Jun 1987 A
4709562 Matsuda Dec 1987 A
4748078 Doi et al. May 1988 A
4759354 Quarfoot Jul 1988 A
4769038 Bendavid et al. Sep 1988 A
4796603 Dahlke et al. Jan 1989 A
4813942 Alvarez Mar 1989 A
4841962 Berg et al. Jun 1989 A
4854316 Davis Aug 1989 A
4925294 Geshwind et al. May 1990 A
4931546 Tardy et al. Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4948540 Nigam Aug 1990 A
4950483 Ksander et al. Aug 1990 A
4970298 Silver et al. Nov 1990 A
4976737 Leake Dec 1990 A
5002551 Linsky et al. Mar 1991 A
5015584 Brysk May 1991 A
5116357 Eberbach May 1992 A
5147374 Fernandez Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5195542 Gazielly et al. Mar 1993 A
5196185 Silver et al. Mar 1993 A
5201745 Tayot et al. Apr 1993 A
5201764 Kelman et al. Apr 1993 A
5206028 Li Apr 1993 A
5217493 Raad et al. Jun 1993 A
5254133 Seid Oct 1993 A
5256418 Kemp et al. Oct 1993 A
5258000 Gianturco Nov 1993 A
5263983 Yoshizato et al. Nov 1993 A
5304595 Rhee et al. Apr 1994 A
5306500 Rhee et al. Apr 1994 A
5308663 Nakagawa May 1994 A
5324775 Rhee et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334527 Brysk Aug 1994 A
5339657 McMurray Aug 1994 A
5350583 Yoshizato et al. Sep 1994 A
5356432 Rutkow et al. Oct 1994 A
5368549 McVicker Nov 1994 A
5368602 de la Torre Nov 1994 A
5370650 Tovey et al. Dec 1994 A
5376375 Rhee et al. Dec 1994 A
5376376 Li Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5399361 Song et al. Mar 1995 A
5413791 Rhee et al. May 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5428022 Palefsky et al. Jun 1995 A
5433996 Kranzler et al. Jul 1995 A
5441491 Verschoor et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5456693 Conston et al. Oct 1995 A
5456711 Hudson Oct 1995 A
5466462 Rosenthal et al. Nov 1995 A
5480644 Freed Jan 1996 A
5487895 Dapper et al. Jan 1996 A
5490984 Freed Feb 1996 A
5512291 Li Apr 1996 A
5512301 Song et al. Apr 1996 A
5514181 Light et al. May 1996 A
5522840 Krajicek Jun 1996 A
5523348 Rhee et al. Jun 1996 A
5536656 Kemp et al. Jul 1996 A
5543441 Rhee et al. Aug 1996 A
5565210 Rosenthal et al. Oct 1996 A
5567806 Abdul-Malak et al. Oct 1996 A
5569273 Titone et al. Oct 1996 A
RE35399 Eisenberg Dec 1996 E
5593441 Lichtenstein et al. Jan 1997 A
5595621 Light et al. Jan 1997 A
5601571 Moss Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5607590 Shimizu Mar 1997 A
5614587 Rhee et al. Mar 1997 A
5618551 Tardy et al. Apr 1997 A
5634931 Kugel Jun 1997 A
5639796 Lee Jun 1997 A
5665391 Lea Sep 1997 A
5667839 Berg Sep 1997 A
5676967 Williams et al. Oct 1997 A
5681568 Goldin et al. Oct 1997 A
5686090 Schilder et al. Nov 1997 A
5686115 Vournakis et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5695525 Mulhauser et al. Dec 1997 A
5697978 Sgro Dec 1997 A
5700476 Rosenthal et al. Dec 1997 A
5700477 Rosenthal et al. Dec 1997 A
5702416 Kieturakis et al. Dec 1997 A
5709934 Bell et al. Jan 1998 A
5711960 Shikinami Jan 1998 A
5716409 Debbas Feb 1998 A
5720981 Eisinger Feb 1998 A
5732572 Litton Mar 1998 A
5743917 Saxon Apr 1998 A
5749895 Sawyer et al. May 1998 A
5752974 Rhee et al. May 1998 A
5756111 Yoshikawa May 1998 A
5766246 Mulhauser et al. Jun 1998 A
5766631 Arnold Jun 1998 A
5769864 Kugel Jun 1998 A
5771716 Schlussel Jun 1998 A
5785983 Furlan et al. Jul 1998 A
5800541 Rhee et al. Sep 1998 A
5814328 Gunasekaran Sep 1998 A
5833705 Ken et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5861034 Taira et al. Jan 1999 A
5863984 Doillon et al. Jan 1999 A
5869080 McGregor et al. Feb 1999 A
5871767 Dionne et al. Feb 1999 A
5876444 Lai Mar 1999 A
5891558 Bell et al. Apr 1999 A
5899909 Claren et al. May 1999 A
5900479 Glasser May 1999 A
5906937 Sugiyama et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5911731 Pham et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5919233 Knopf et al. Jul 1999 A
5922026 Chin Jul 1999 A
5931165 Reich et al. Aug 1999 A
5942278 Hagedorn et al. Aug 1999 A
5962136 Dewez et al. Oct 1999 A
5972022 Huxel Oct 1999 A
RE36370 Li Nov 1999 E
5993844 Abraham et al. Nov 1999 A
5994325 Roufa et al. Nov 1999 A
5997895 Narotam et al. Dec 1999 A
6001895 Harvey et al. Dec 1999 A
6008292 Lee et al. Dec 1999 A
6015844 Harvey et al. Jan 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6043089 Sugiyama et al. Mar 2000 A
6051425 Morota et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6056970 Greenawalt et al. May 2000 A
6057148 Sugiyama et al. May 2000 A
6063396 Kelleher May 2000 A
6066776 Goodwin et al. May 2000 A
6066777 Benchetrit May 2000 A
6071292 Makower et al. Jun 2000 A
6077281 Das Jun 2000 A
6080194 Pachence et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6090116 D'Aversa et al. Jul 2000 A
6113623 Sgro Sep 2000 A
6120539 Eldridge et al. Sep 2000 A
6132765 DiCosmo et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153292 Bell et al. Nov 2000 A
6162962 Hinsch et al. Dec 2000 A
6165488 Tardy et al. Dec 2000 A
6171318 Kugel et al. Jan 2001 B1
6174320 Kugel et al. Jan 2001 B1
6176863 Kugel et al. Jan 2001 B1
6179872 Bell et al. Jan 2001 B1
6180848 Flament et al. Jan 2001 B1
6197325 MacPhee et al. Mar 2001 B1
6197934 DeVore et al. Mar 2001 B1
6197935 Doillon et al. Mar 2001 B1
6210439 Firmin et al. Apr 2001 B1
6214020 Mulhauser et al. Apr 2001 B1
6221109 Geistlich et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6258124 Darois et al. Jul 2001 B1
6262332 Ketharanathan Jul 2001 B1
6264702 Ory et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6270530 Eldridge et al. Aug 2001 B1
6277397 Shimizu Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6306079 Trabucco Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312474 Francis et al. Nov 2001 B1
6319264 Tormala et al. Nov 2001 B1
6328686 Kovac Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6383201 Dong May 2002 B1
6391060 Ory et al. May 2002 B1
6391333 Li et al. May 2002 B1
6391939 Tayot et al. May 2002 B2
6408656 Ory et al. Jun 2002 B1
6410044 Chudzik et al. Jun 2002 B1
6413742 Olsen et al. Jul 2002 B1
6425924 Rousseau Jul 2002 B1
6428978 Olsen et al. Aug 2002 B1
6436030 Rehil Aug 2002 B2
6440167 Shimizu Aug 2002 B2
6443964 Ory et al. Sep 2002 B1
6447551 Goldmann Sep 2002 B1
6447802 Sessions et al. Sep 2002 B2
6448378 DeVore et al. Sep 2002 B2
6451032 Ory et al. Sep 2002 B1
6451301 Sessions et al. Sep 2002 B1
6454787 Maddalo et al. Sep 2002 B1
6477865 Matsumoto Nov 2002 B1
6479072 Morgan et al. Nov 2002 B1
6485503 Jacobs et al. Nov 2002 B2
6500464 Ceres et al. Dec 2002 B2
6500777 Wiseman et al. Dec 2002 B1
6509031 Miller et al. Jan 2003 B1
6511958 Atkinson et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6514514 Atkinson et al. Feb 2003 B1
6540773 Dong Apr 2003 B2
6541023 Andre et al. Apr 2003 B1
6548077 Gunasekaran Apr 2003 B1
6554855 Dong Apr 2003 B1
6559119 Burgess et al. May 2003 B1
6566345 Miller et al. May 2003 B2
6575988 Rousseau Jun 2003 B2
6576019 Atala Jun 2003 B1
6596002 Therin et al. Jul 2003 B2
6596304 Bayon et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
6599524 Li et al. Jul 2003 B2
6599690 Abraham et al. Jul 2003 B1
6610006 Amid et al. Aug 2003 B1
6613348 Jain Sep 2003 B1
6616685 Rousseau Sep 2003 B2
6623963 Muller et al. Sep 2003 B1
6630414 Matsumoto Oct 2003 B1
6637437 Hungerford et al. Oct 2003 B1
6638284 Rousseau et al. Oct 2003 B1
6645226 Jacobs et al. Nov 2003 B1
6652594 Francis et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
6653450 Berg et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6660280 Allard et al. Dec 2003 B1
6669735 Pelissier Dec 2003 B1
6670018 Fujita et al. Dec 2003 B2
6682760 Noff et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6706684 Bayon et al. Mar 2004 B1
6706690 Reich et al. Mar 2004 B2
6712859 Rousseau et al. Mar 2004 B2
6719795 Cornwall et al. Apr 2004 B1
6723335 Moehlenbruck et al. Apr 2004 B1
6726660 Hessel et al. Apr 2004 B2
6730299 Tayot et al. May 2004 B1
6736823 Darois et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6737371 Planck et al. May 2004 B1
6743435 DeVore et al. Jun 2004 B2
6746458 Cloud Jun 2004 B1
6752834 Geistlich et al. Jun 2004 B2
6755868 Rousseau Jun 2004 B2
6773723 Spiro et al. Aug 2004 B1
6783554 Amara et al. Aug 2004 B2
6790213 Cherok et al. Sep 2004 B2
6790454 Abdul Malak et al. Sep 2004 B1
6800082 Rousseau Oct 2004 B2
6833408 Sehl et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6852330 Bowman et al. Feb 2005 B2
6869938 Schwartz et al. Mar 2005 B1
6872227 Sump et al. Mar 2005 B2
6893653 Abraham et al. May 2005 B2
6896904 Spiro et al. May 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6936276 Spiro et al. Aug 2005 B2
6939562 Spiro et al. Sep 2005 B2
6949625 Tayot Sep 2005 B2
6966918 Schuldt-Hempe et al. Nov 2005 B1
6971252 Therin et al. Dec 2005 B2
6974679 Andre et al. Dec 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
6977231 Matsuda Dec 2005 B1
6984392 Bechert et al. Jan 2006 B2
6988386 Okawa et al. Jan 2006 B1
7011688 Gryska et al. Mar 2006 B2
7021086 Ory et al. Apr 2006 B2
7022358 Eckmayer et al. Apr 2006 B2
7025063 Snitkin et al. Apr 2006 B2
7041868 Greene et al. May 2006 B2
7060103 Carr, Jr. et al. Jun 2006 B2
RE39172 Bayon et al. Jul 2006 E
7070558 Gellman et al. Jul 2006 B2
7087065 Ulmsten et al. Aug 2006 B2
7094261 Zotti et al. Aug 2006 B2
7098315 Schaufler Aug 2006 B2
7101381 Ford et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7156804 Nicolo Jan 2007 B2
7156858 Schuldt-Hempe et al. Jan 2007 B2
7175852 Simmoteit et al. Feb 2007 B2
7192604 Brown et al. Mar 2007 B2
7207962 Anand et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7226611 Yura et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7252837 Guo et al. Aug 2007 B2
7279177 Looney et al. Oct 2007 B2
7331199 Ory et al. Feb 2008 B2
7393319 Merade et al. Jul 2008 B2
7556598 Rao Jul 2009 B2
7594921 Browning Sep 2009 B2
7614258 Cherok et al. Nov 2009 B2
7615065 Priewe et al. Nov 2009 B2
7662169 Wittmann Feb 2010 B2
7670380 Cauthen, III Mar 2010 B2
7682381 Rakos et al. Mar 2010 B2
7709017 Tayot May 2010 B2
7718556 Matsuda et al. May 2010 B2
7732354 Fricke et al. Jun 2010 B2
7785334 Ford et al. Aug 2010 B2
7789888 Bartee et al. Sep 2010 B2
7799767 Lamberti et al. Sep 2010 B2
7806905 Ford et al. Oct 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7828854 Rousseau et al. Nov 2010 B2
7900484 Cherok et al. Mar 2011 B2
7931695 Ringeisen Apr 2011 B2
8052759 Dupic et al. Nov 2011 B2
8079023 Chen Dec 2011 B2
8100924 Browning Jan 2012 B2
8123817 Intoccia et al. Feb 2012 B2
8142515 Therin et al. Mar 2012 B2
8157821 Browning Apr 2012 B2
8157822 Browning Apr 2012 B2
8182545 Cherok et al. May 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8206632 Rousseau et al. Jun 2012 B2
8215310 Browning Jul 2012 B2
8317872 Adams Nov 2012 B2
8323675 Greenawalt Dec 2012 B2
8343232 Adzich et al. Jan 2013 B2
8366787 Brown et al. Feb 2013 B2
8435307 Paul May 2013 B2
8470355 Skalla et al. Jun 2013 B2
8562633 Cully et al. Oct 2013 B2
8574627 Martakos et al. Nov 2013 B2
8709094 Stad et al. Apr 2014 B2
8734471 Deitch May 2014 B2
8753360 Gleiman et al. Jun 2014 B2
8758800 Stopek et al. Jun 2014 B2
8784294 Goddard Jul 2014 B2
8814887 Walther et al. Aug 2014 B2
8828092 Toso et al. Sep 2014 B2
8834864 Odar et al. Sep 2014 B2
8846060 Archibald et al. Sep 2014 B2
8865215 Ladet et al. Oct 2014 B2
8877233 Obermiller et al. Nov 2014 B2
8911504 Mathisen et al. Dec 2014 B2
8920370 Sholev et al. Dec 2014 B2
8956373 Ford et al. Feb 2015 B2
8962006 Bayon et al. Feb 2015 B2
8968762 Ladet et al. Mar 2015 B2
8979935 Lozier et al. Mar 2015 B2
9034357 Stopek May 2015 B2
9113993 Lee Aug 2015 B2
9211175 Stopek et al. Dec 2015 B2
9216075 Bailly et al. Dec 2015 B2
20020064551 Edwards May 2002 A1
20020087174 Capello Jul 2002 A1
20020095218 Carr et al. Jul 2002 A1
20030055211 Roberts Mar 2003 A1
20030086975 Ringeisen May 2003 A1
20030091851 Khor May 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030133967 Ruszczak et al. Jul 2003 A1
20030225355 Butler Dec 2003 A1
20040034373 Schuldt-Hempe et al. Feb 2004 A1
20040054376 Ory et al. Mar 2004 A1
20040058013 Taylor Mar 2004 A1
20040059356 Gingras Mar 2004 A1
20040101546 Gorman et al. May 2004 A1
20040243043 McCarthy Dec 2004 A1
20050002893 Goldmann Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050085924 Darois et al. Apr 2005 A1
20050113849 Popadiuk et al. May 2005 A1
20050137512 Campbell et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050148963 Brennan Jul 2005 A1
20050175659 Macomber et al. Aug 2005 A1
20050232979 Shoshan Oct 2005 A1
20050267521 Forsberg Dec 2005 A1
20050288691 Leiboff Dec 2005 A1
20060116696 Odermatt et al. Jun 2006 A1
20060135921 Wiercinski et al. Jun 2006 A1
20060147501 Hillas et al. Jul 2006 A1
20060159732 Cullen Jul 2006 A1
20060172000 Cullen Aug 2006 A1
20060216320 Kitazono et al. Sep 2006 A1
20060252981 Matsuda et al. Nov 2006 A1
20060253203 Alvarado Nov 2006 A1
20060282103 Fricke et al. Dec 2006 A1
20070032805 Therin Feb 2007 A1
20070088391 McAlexander et al. Apr 2007 A1
20070129736 Solecki Jun 2007 A1
20070198040 Buevich et al. Aug 2007 A1
20070237811 Scherr Oct 2007 A1
20070299538 Roeber Dec 2007 A1
20080091276 Deusch et al. Apr 2008 A1
20080109017 Herweck et al. May 2008 A1
20080113001 Herweck et al. May 2008 A1
20080172071 Barker Jul 2008 A1
20080181936 Filatov Jul 2008 A1
20080255593 St-Germain Oct 2008 A1
20090035341 Wagener et al. Feb 2009 A1
20090036996 Roeber Feb 2009 A1
20090068250 Gravagna et al. Mar 2009 A1
20090105526 Piroli Torelli et al. Apr 2009 A1
20090163936 Yang et al. Jun 2009 A1
20090187197 Roeber et al. Jul 2009 A1
20090192530 Adzich et al. Jul 2009 A1
20090204129 Fronio Aug 2009 A1
20090216338 Gingras et al. Aug 2009 A1
20090270999 Brown Oct 2009 A1
20090281558 Li Nov 2009 A1
20090318752 Evans et al. Dec 2009 A1
20100104608 Abuzaina et al. Apr 2010 A1
20100318108 Datta et al. Dec 2010 A1
20110015760 Kullas Jan 2011 A1
20110144667 Horton et al. Jun 2011 A1
20110190795 Hotter et al. Aug 2011 A1
20110238094 Thomas et al. Sep 2011 A1
20110251699 Ladet Oct 2011 A1
20110257666 Ladet et al. Oct 2011 A1
20110311632 Roorda Dec 2011 A1
20120016388 Houard et al. Jan 2012 A1
20120022242 Domard Jan 2012 A1
20120029537 Mortarino Feb 2012 A1
20120065727 Reneker et al. Mar 2012 A1
20120082712 Stopek et al. Apr 2012 A1
20120093686 Kirsch Apr 2012 A1
20120116425 Intoccia et al. May 2012 A1
20120150204 Mortarino et al. Jun 2012 A1
20120165937 Montanari et al. Jun 2012 A1
20120179175 Hammell Jul 2012 A1
20120179176 Wilson et al. Jul 2012 A1
20120197415 Montanari et al. Aug 2012 A1
20130287836 Ingber Oct 2013 A1
20140044861 Boey et al. Feb 2014 A1
20140364684 Lecuivre Dec 2014 A1
Foreign Referenced Citations (133)
Number Date Country
1317836 May 1993 CA
201879864 Jun 2011 CN
19544162 Apr 1997 DE
19718903 Dec 1997 DE
19751733 Dec 1998 DE
19832634 Jan 2000 DE
10019604 Oct 2001 DE
10120942 Oct 2001 DE
10043396 Jun 2002 DE
0194192 Sep 1986 EP
0248544 Dec 1987 EP
0263360 Apr 1988 EP
0276890 Aug 1988 EP
0372969 Jun 1990 EP
0531742 Mar 1993 EP
544485 Jun 1993 EP
0552576 Jul 1993 EP
0611561 Aug 1994 EP
614650 Sep 1994 EP
0621014 Oct 1994 EP
0625891 Nov 1994 EP
0637452 Feb 1995 EP
0664132 Jul 1995 EP
0705878 Apr 1996 EP
0719527 Jul 1996 EP
0774240 May 1997 EP
0797962 Oct 1997 EP
0800791 Oct 1997 EP
827724 Mar 1998 EP
0836838 Apr 1998 EP
0847727 Jun 1998 EP
0876808 Nov 1998 EP
0895762 Feb 1999 EP
898944 Mar 1999 EP
1017415 Jul 2000 EP
1036545 Sep 2000 EP
1052319 Nov 2000 EP
1055757 Nov 2000 EP
1090590 Apr 2001 EP
1 216 717 Jun 2002 EP
1 216 718 Jun 2002 EP
0693523 Nov 2002 EP
1315468 Jun 2003 EP
1382728 Jan 2004 EP
1484070 Dec 2004 EP
1561480 Aug 2005 EP
1645232 Apr 2006 EP
1674048 Jun 2006 EP
1691606 Aug 2006 EP
1782848 May 2007 EP
1 952 828 Aug 2008 EP
2229918 Sep 2010 EP
2244853 Apr 1975 FR
2257262 Aug 1975 FR
2 308 349 Nov 1976 FR
2453231 Oct 1980 FR
2612392 Sep 1988 FR
2715309 Jul 1995 FR
2715405 Jul 1995 FR
2 724 563 Mar 1996 FR
2730406 Aug 1996 FR
2744906 Aug 1997 FR
2766698 Feb 1999 FR
2771622 Jun 1999 FR
2773057 Jul 1999 FR
2774277 Aug 1999 FR
2779937 Dec 1999 FR
2859624 Mar 2005 FR
2863277 Jun 2005 FR
2876020 Apr 2006 FR
2884706 Oct 2006 FR
2929834 Oct 2009 FR
2953709 Jun 2011 FR
1174814 Dec 1969 GB
2 051 153 Jan 1981 GB
2306110 Apr 1997 GB
H0332677 Feb 1991 JP
H05237128 Sep 1993 JP
H09137380 May 1997 JP
H11146888 Jun 1999 JP
2008538300 Oct 2008 JP
2011078767 Apr 2011 JP
8902445 Mar 1989 WO
8908467 Sep 1989 WO
9012551 Nov 1990 WO
9206639 Apr 1992 WO
9220349 Nov 1992 WO
9311805 Jun 1993 WO
9310731 Jun 1993 WO
9318174 Sep 1993 WO
9417747 Aug 1994 WO
9507666 Mar 1995 WO
9518638 Jul 1995 WO
9532687 Dec 1995 WO
9603091 Feb 1996 WO
9608277 Mar 1996 WO
9609795 Apr 1996 WO
9614805 May 1996 WO
9641588 Dec 1996 WO
9735533 Oct 1997 WO
9835632 Aug 1998 WO
9849967 Nov 1998 WO
9905990 Feb 1999 WO
9906079 Feb 1999 WO
9906080 Feb 1999 WO
9951163 Oct 1999 WO
0016821 Mar 2000 WO
0067663 Nov 2000 WO
0115625 Mar 2001 WO
0180773 Nov 2001 WO
0181667 Nov 2001 WO
0207648 Jan 2002 WO
0217853 Mar 2002 WO
02078568 Oct 2002 WO
03002168 Jan 2003 WO
2004004600 Jan 2004 WO
2004071349 Aug 2004 WO
2004078120 Sep 2004 WO
2004103212 Dec 2004 WO
2005011280 Feb 2005 WO
2005013863 Feb 2005 WO
2005018698 Mar 2005 WO
2005048708 Jun 2005 WO
2005105172 Nov 2005 WO
2006018552 Feb 2006 WO
2006023414 Mar 2006 WO
2007048099 Apr 2007 WO
2009031035 Mar 2009 WO
2009071998 Jun 2009 WO
2010043978 Apr 2010 WO
2011026987 Mar 2011 WO
2011038740 Apr 2011 WO
WO 2011066471 Jun 2011 WO
Non-Patent Literature Citations (36)
Entry
Australian Office Action issued Apr. 8, 2016 in corresponding Australian Patent Application No. 2013322689, 3 pages.
Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllum Nodosum,” Anticancer Res., Nov.-Dec. 1993, pp. 2011-2020, 12 (6A).
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36.
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7).
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004.
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165.
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4).
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009.
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26.
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63.
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5.
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299.
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4).
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220,18(2).
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4).
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3).
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007.
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003.
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1).
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2).
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10.
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5).
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6).
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2.
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3).
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19.
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34.
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136.
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25.
Preliminary Search Report from French Patent Office dated Dec. 20, 2006, 3 pages.
Lamarque, G. et al, “New Route of Deacetylation of alpha- and beta-Chitins by Means of Freeze-Pump Out-Thaw Cycles” Biomacromolecules, May-Jun. 2005, pp. 1380-1388, 6.
Lamarque, G. et al., Comparative Study of the First Heterogeneous Deacetylation of alpha- and beta-Chitins in a Multistep Process Biomacromolecules May-Jun. 2004, 992-1001, 5.
Lamarque, G. et al., “Comparative Study of the Second and Third Heterogeneous Deacetylations of alpha- and beta-Chitins in a Multistep Process” Biomacromolecules, Sep.-Oct. 5, 2004, pp. 1899-1907, 5.
Tolaimate, A., et al. “Contribution to the preparation of chitins and chitosans with controlled physico-chemical properties.” Polymer, Dec. 2003, pp. 7939-7952, 44 (26).
International Search Report for PCT/EP13/069957 date of completion is Feb. 25, 2014 (2 pages).
European Office Action issued Nov. 4, 2016 in corresponding European Patent Application No. 13766967.7, 5 pages.
Related Publications (1)
Number Date Country
20150202342 A1 Jul 2015 US